Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,798 | -31,789 | -14,833 | -10,074 | -3,317 |
| Depreciation Amortization | 638 | 1,865 | 1,441 | 844 | 691 |
| Accounts receivable | N/A | -2,368 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | N/A | 8,185 | N/A | N/A | N/A |
| Other Working Capital | 3,063 | 4,075 | -2,349 | -469 | -2,143 |
| Other Operating Activity | 2,212 | 15,841 | 8,199 | 5,780 | 1,950 |
| Operating Cash Flow | $-2,885 | $-4,191 | $-7,542 | $-3,919 | $-2,819 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -56 | -405 | -248 | -138 | -66 |
| Net Acquisitions | N/A | -12,904 | -12,903 | -12,500 | -12,500 |
| Purchase Sale Intangibles | -1,926 | -9,659 | -7,080 | -4,492 | -1,397 |
| Other Investing Activity | -1,926 | -9,659 | -7,080 | -4,492 | -1,397 |
| Investing Cash Flow | $-1,982 | $-22,968 | $-20,231 | $-17,130 | $-13,963 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,000 | 30,176 | 28,175 | 28,175 | 21,676 |
| Common Stock Issued | 548 | 7,391 | 6,847 | -270 | N/A |
| Other Financing Activity | -811 | -8,757 | -8,018 | -5,143 | -2,830 |
| Financing Cash Flow | $3,737 | $28,810 | $27,004 | $22,762 | $18,846 |
| Exchange Rate Effect | 29 | -175 | -82 | -87 | 21 |
| Beginning Cash Position | 5,167 | 3,691 | 3,691 | 3,691 | 3,691 |
| End Cash Position | 4,066 | 5,167 | 2,840 | 5,317 | 5,776 |
| Net Cash Flow | $-1,101 | $1,476 | $-851 | $1,626 | $2,085 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,885 | -4,191 | -7,542 | -3,919 | -2,819 |
| Capital Expenditure | -56 | -405 | -248 | -138 | -66 |
| Free Cash Flow | -2,941 | -4,596 | -7,790 | -4,057 | -2,885 |